Clinical Trials on Moderate to Severe Secondary Hyperparathyroidism
Total 970 results
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
AbbVieRecruitingChronic Kidney Disease (CKD) | Secondary Hyperparathyroidism (SHPT)United States, Puerto Rico
-
Washington University School of MedicineAbbott; NorthShore University HealthSystem; Northwestern University Feinberg... and other collaboratorsCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
AbbottAbbott Japan Co.,LtdCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease on HemodialysisJapan
-
AbbVie (prior sponsor, Abbott)CompletedSecondary Hyperparathyroidism | Kidney InsufficiencyAustria, Germany
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingSecondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on HemodialysisChina
-
Chulalongkorn UniversityCompletedHyperparathyroidism, SecondaryThailand
-
Saint Petersburg State University, RussiaCompletedHypocalcemia | Secondary Hyperparathyroidism | Dialysis | Hypoparathyroidism | Chronic Kidney Disease-Mineral and Bone DisorderRussian Federation
-
Károli Gáspár University of the Reformed Church...University of TorontoCompletedMild to Moderate Psychopathological SymptomsHungary
-
Károli Gáspár University of the Reformed Church...University of TorontoCompletedMild to Moderate Psychopathological SymptomsHungary
-
TheraclionWithdrawnEnd Stage Renal Disease | Secondary Hyperparathyroidism | Parathyroid HyperplasiaSpain, Italy
-
QRxPharma Inc.CompletedModerate to Severe Postoperative PainUnited States
-
AbbottCompletedEnd Stage Renal Disease | Secondary HyperparathyroidismUnited States
-
AmgenCompletedEnd Stage Renal Disease
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyUnited States
-
AbbottCompletedRenal Insufficiency, Chronic | Hemodialysis | Secondary Hyperparathyroidism | Hypercalcemia | Parathyroid HormonePeru
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)Germany
-
Edwards LifesciencesActive, not recruiting
-
NestléCompletedMild to Moderate Levels of StressSwitzerland
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyCanada, United States
-
Merz North America, Inc.Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
AcelRx Pharmaceuticals, Inc.CompletedAcute Moderate-to-severe PainUnited States
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot FoundationCompletedModerate to Severe DementiaFrance
-
AbbVie (prior sponsor, Abbott)CompletedSecondary Hyperparathyroidism | Chronic Kidney FailureGreece
-
Clalit Health ServicesCompletedVitamin D Deficiency | Secondary Hyperparathyroidism | OsteomalaciaIsrael
-
The University of Hong KongCompletedVascular Diseases | Secondary Hyperparathyroidism | Kidney FailureHong Kong
-
AbbottCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease, Stage 5United States
-
Grünenthal GmbHDepomedTerminatedModerate to Severe Acute Postoperative PainUnited States, United Kingdom, Poland
-
University Medical Center GroningenCompletedPrimary Hyperparathyroidism | Primary Hyperparathyroidism Due to Adenoma
-
Al-Azhar UniversityEnrolling by invitationModerate and Severe Crowding in Lower Dental ArchEgypt
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
AbbVie (prior sponsor, Abbott)Pharma Consulting Group ABCompletedChronic Kidney Disease | Secondary HyperparathyroidismSweden
-
Salem Veterans Affairs Medical CenterAbbottCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
Tishreen UniversityCompletedMild to Moderate Anterior Mandibular Segment CrowdindSyrian Arab Republic
-
AbbVie (prior sponsor, Abbott)CompletedChronic Kidney Disease | Secondary HyperparathyroidismGreece
-
University of VirginiaWithdrawnChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
UCB Biopharma S.P.R.L.CompletedModerate to Severe Psoriasis | Generalized Pustular Psoriasis and Erythrodermic PsoriasisJapan
-
Lindner Center of HOPEUniversity of Cincinnati; AbbottCompletedBipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild ManiaUnited States
-
Guangdong Provincial People's HospitalCompletedHyperparathyroidism, Secondary | Hyperkalemia | Sodium Zirconium Cyclosilicate
-
Yonsei UniversityRecruitingModerate to Severe Dry EyeKorea, Republic of
-
Charite University, Berlin, GermanyWyeth is now a wholly owned subsidiary of PfizerUnknownModerate to Severe Active Axial SpondyloarthritisGermany
-
LG Life SciencesUnknownNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar RegionKorea, Republic of
-
Zealand University HospitalTerminatedVitamin D Deficiency | Chronic Kidney Disease | Secondary HyperparathyroidismDenmark
-
PfizerTerminatedModerate-severe PainUnited States
-
AbbVie (prior sponsor, Abbott)Assign Data Management and Biostatistics GmbHCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease Stage V | Cardiac MorbidityAustria
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyUnited States
-
AmgenCompleted